Life Science Insights Series

The time has come when innovation is desperately needed in the field of bio business development. The traditional “technology-driven” approach is gradually losing relevance. Instead, a strategic, “market-driven” approach that emphasizes unmet needs and highlights market impact is emerging as the new standard. Rather than traditional “outbound” sales tactics, there is growing consensus that innovative inbound strategies that allow businesses to be “discovered” are opening new doors for bio business development.

In response, Pharm News (www.pharmnews.com) has partnered with Dr. Jake Lee—who has led business development for companies like Lonza, Shire, and Pfizer across North America for over 20 years—and global inbound marketing expert Professor Suzy Im to co-create a new column series titled “Success Strategies and Insights.” This series will support Korean pharma-bio companies with their business development and market innovation efforts, especially in the post-COVID-19 era.

The series will actively share insights from the highly acclaimed BDMT Global team’s regular seminars, highlight global company case studies, and offer trend analyses and strategic insights from Boston, one of the world’s leading biotech hubs.

Industry Reports

Strategic Research Collaborations for Market Acceptance: Fate Therapeutics’ Growth Strategies

Positive Perception Grows for South Korea-Based Biotechs Seeking to Revitalize the Local Economy Through U.S. Startup Deals and Expansion

JW Pharmaceutical Lands First-Of-Its-Kind Deal with Leading Venture Firm Amidst U.S. Biotech Advancement Efforts

Connecting with Caregivers to Encourage Medication Adoption in Patient End-Users – Analysis of LYNPARZA’s Targeted U.S. Assets

Bioslice’s Professional Society Relationship Building Efforts for Osteoarthritis Market Awareness – Tips for Developers

Horizon Therapeutics’ Focus on Local Community Movements Aids in $3B Annual Sales

The BeginNGS of Newborn Screening Test Market Disruption and Innovation – Core U.S. Soft Launch Strategies Examined

Leveraging Community Machine Learning Competitions to Accelerate Industry Adoption and References – Cellarity

How EQRx Conducted Strategic Branding Initiatives to Secure Pharmaceutical Supporters and Partners

Analyzing Exscientia’s Multi-Tier, Multi-Million Dollar Business Development Strategies

HiberCell’s Early Business Development Strategy for Long-Term Pipeline Development

Exploring Biogen’s Failed Crisis Response Efforts in 2019 and Their Current Repositioning Efforts in the Alzheimer’s Community

Launching a New Indication in the US Neurogenderative Disease Market – Lessons from Denali Therapeutics’ Targeted Content

Launching a D2C Consumer Line to Generate 9.9M in Revenue and Supporters While Conducting Clinical Trials for Topical Biotherapeutics

Creating a Partner Ecosystem to Accelerate Product Adoption in Patient Communities with Key Unmet Needs – Analysis of Hologic’s Movement

How a Prescription Medical Device Disrupted the Chronic Pain Pill Market – Strategies for Pharma to Take Note of and Potential Opportunities to Explore

Creating Profitability and Expanded Value as an Orphan Drug Manufacturer – BLINCYTO’s Unique, Initial Market Offerings Explored

Building Support in US-Based Medical and Patient Communities Years Before Launching – Successful Partnering Case

Keytruda’s “Tru” Underdog Story: From Last on the Asset List to Merck’s Top Selling Product

Launching a Biopharmaceutical Marketing Campaign Around Industry Trade Shows – Kite Pharma’s Pre-FDA Approved Strategy

From Rapid Success to Recovery: Alnylam Pharmaceuticals’ Resilience Through Key Processes

Focused to Flourish: How Verve Therapeutics Used a Niche Strategy to Take on Cardiovascular Disease

Timing the Market Out of the Lab, Into the Limelight: How Arvinas Used Smart Positioning to Secure Early Wins

Circular RNA Technology: Gaining Traction in the RNA Therapeutics Landscape